These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3674847)

  • 1. Antifungal activity of the allylamine derivative terbinafine in vitro.
    Petranyi G; Meingassner JG; Mieth H
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1365-8. PubMed ID: 3674847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro studies with SF 86-327, a new orally active allylamine derivative.
    Shadomy S; Espinel-Ingroff A; Gebhart RJ
    Sabouraudia; 1985 Apr; 23(2):125-32. PubMed ID: 2990057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison.
    Hazen KC
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S37-41. PubMed ID: 9594935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of naftifine, a new antifungal agent.
    Georgopoulos A; Petranyi G; Mieth H; Drews J
    Antimicrob Agents Chemother; 1981 Mar; 19(3):386-9. PubMed ID: 7247366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro spectrum of action of a new antifungal derivative of naftifin: terbinafin (SF 86-327)].
    Goudard M; Buffard Y; Ferrari H; Regli P
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):680-3. PubMed ID: 3534767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.
    Carrillo-Muñoz AJ; Guglietta A; Palacín C; Casals J; del Valle O; Guardià C; Rodríguez V; Quindós G
    Chemotherapy; 2004 Dec; 50(6):308-13. PubMed ID: 15608448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of bifonazole (BAY H 4502) with clotrimazole in vitro.
    Shadomy S; Dixon DM; May R
    Sabouraudia; 1982 Dec; 20(4):313-23. PubMed ID: 7157107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidermatophytic activity of allylamine derivatives.
    Venugopal PV; Venugopal TV
    Indian J Pathol Microbiol; 1994 Oct; 37(4):381-8. PubMed ID: 7868170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of terbinafine against serious fungal pathogens.
    Ryder NS
    Mycoses; 1999; 42 Suppl 2():115-9. PubMed ID: 10865917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of terbinafine in experimental fungal infections of laboratory animals.
    Petranyi G; Meingassner JG; Mieth H
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1558-61. PubMed ID: 3435103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of in vitro activity of ciclopirox olamine, butenafine HCl and econazole nitrate against dermatophytes, yeasts and bacteria.
    Kokjohn K; Bradley M; Griffiths B; Ghannoum M
    Int J Dermatol; 2003 Sep; 42 Suppl 1():11-7. PubMed ID: 12895182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses.
    Clayton YM
    Br J Dermatol; 1994 Apr; 130 Suppl 43():7-8. PubMed ID: 8186143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of antifungal activity of sertaconazole, terbinafine, and bifonazole against clinical isolates of Candida spp., Cryptococcus neoformans and dermatophytes.
    Carillo-Muñoz AJ; Tur-Tur C
    Chemotherapy; 1997; 43(6):387-92. PubMed ID: 9395851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
    Bhatia VK; Sharma PC
    Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro action spectrum of a new antifungal agent derived from morpholine: amorolfin].
    Regli P; Ferrari H
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):617-20. PubMed ID: 2797885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of terbinafine against cutaneous isolates of Candida albicans and other pathogenic yeasts.
    Ryder NS; Wagner S; Leitner I
    Antimicrob Agents Chemother; 1998 May; 42(5):1057-61. PubMed ID: 9593126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes.
    Fernández-Torres B; Cabañes FJ; Carrillo-Muñoz AJ; Esteban A; Inza I; Abarca L; Guarro J
    J Clin Microbiol; 2002 Nov; 40(11):3999-4003. PubMed ID: 12409365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disk diffusion susceptibility testing of dermatophytes with allylamines.
    Venugopal PV; Venugopal TV
    Int J Dermatol; 1994 Oct; 33(10):730-2. PubMed ID: 8002146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the susceptibility of dermatophytes to antifungal drugs: a new technique.
    Butty P; Lebecq JC; Mallié M; Bastide JM
    J Med Vet Mycol; 1995; 33(6):403-9. PubMed ID: 8683409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.